Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep. 204: "One Health", and Innovations in Agricultural Disease Surveillance - Dr. Alan Rudolph

Ep. 204: "One Health", and Innovations in Agricultural Disease Surveillance - Dr. Alan Rudolph

FromHalteres Presents


Ep. 204: "One Health", and Innovations in Agricultural Disease Surveillance - Dr. Alan Rudolph

FromHalteres Presents

ratings:
Length:
53 minutes
Released:
Aug 1, 2023
Format:
Podcast episode

Description

On this week's episode, Rich Thayer and Mickey Urdea are interviewing Dr. Alan Rudolph, who has had an active career in translating interdisciplinary life sciences into useful applications for biotechnology development in academia, government laboratories, and the nonprofit and private sectors. Dr. Rudolph spearheads a wide-ranging discussion on innovations in disease surveillance in agriculture, the viability of developing veterinary diagnostics tests, what "One Health" represents for whole ecosystem health, and the values of longitudinal sampling, among many other interesting topics. Sit down and tune into this electric discussion with Dr. Alan Rudolph.

Dr. Alan Rudolph is the former Vice President for Research at Colorado State University, and a former member of the Senior Executive Service, having served as the Director for Chemical and Biological Technologies Directorate, Research and Development Enterprise, Defense Threat Reduction Agency (DTRA) as part of the Defense Advanced Research Projects Agency (DARPA).
Released:
Aug 1, 2023
Format:
Podcast episode

Titles in the series (21)

Halteres Presents is a brand-agnostic interview podcast designed to unbiasedly highlight the happenings within the diagnostics industry. In each episode, founding partner Mickey Urdea and managing partner Rich Thayer interview an expert who brings their own unique perspective to an industry topic. Halteres Associates is a leading bioscience consultancy with extensive, long-term, direct operating experience in a broad spectrum of areas of expertise, including the development and commercialization of diagnostics, medical devices, therapeutics, research reagents, and bioscience tools.